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INTRODUCTION
Recent research has attempted to exploit data on thefractions of tumor growth and proliferating cells,thus obtaining a probable measure of tumor
aggressiveness, with the purpose of establishing new
prognostic indicators.
From this information, various methods have been
devised for measuring the proliferative activity of breast
carcinomas: mitotic counts, index of tritiated thymidine,
BrdU, computerized or flow cytometry.
Immunohistochemical methods involving monoclonal
antibodies have been introduced to facilitate studies in this
field.
In 1978, Miyachi et al(1) identified an antibody in the
serum of some patients with systemic erythomatous lupus
that reacted with a nuclear antigen of proliferating cells
(PCNA - Proliferating Cell Nuclear Antigen). This antigen
was later characterized as a 36KDa polypeptide and
described as a specific auxiliary protein of the DNA
polymerase d, necessary for its catalytic activity(2,3).
A monoclonal antibody for this protein was obtained
and retrospective analysis on tumor tissues was then
conducted. These results were similar to the ones attained
by flow cytometry of the same tumor(4,5).
In this way, several investigators reported on the
significance of PCNA, using the mitotic index, grade of
nuclear and histological differentiation, cancer-free survival
and overall survival. They also observed substantial
correlations with other markers of proliferative tumor
activity such as: Ki67, incorporation of tritiated thymidine,
incorporation of bromodeoxyuridine, flow cytometry and
computerized static cytometry. Furthermore, correlations
were also encountered with the protein c-erbB-2, the
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Objective: This study aimed to analyse whether a marker of proliferative activity (PCNA) could provide a prognosis of tumor
evolution and to determine whether different interpretation criteria could alter the results. Method: The presence of PCNA in
59 patients of state II (T2 NO,1 MO) mammary carcinoma was determined. Result: Numerical proportions of total and intensely
stained cells were established. These data were compared with anatomopathological parameters. A significant association
between higher cyclin values and worse histological and nuclear grading was encountered, particularly in patients with a
“negative axilla” using the PCNA index. Cyclin values were not significant in relation to any parameters when indices from the
intensely stained cells were considered exclusively. Conclusion: Higher nuclear (NG3) and histological (HGIII) grading,
associated with a high PCNA index (>50), distinguish high-risk patients, and it is more appropriate considering all the stained
cells as representative of PCNA indices, thus reflecting tumor aggressiveness.
UNITERMS: Breast Cancer. Prognostic Factor. Proliferating cell nuclear antigen (PCNA/cyclin).
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expression of tumor suppressor gene p53, the receptor for
EGF and the absence of hormonal receptors. These
researchers emphasized that this method originated
reproducible and reliable results, its technique was easily
adaptable to laboratorial routines and, above all, involved
low costs(5,6,7,8,9,10,11,12).
Nevertheless, other authors did not confirm these
findings. Their results disagreed with the ones mentioned
or even revealed a total absence of correlation with any
parameter assessing the prognosis of breast cancer(13,14,15).
Since then studies have been published in the
literature always emphasizing the correlation of PCNA-
immunoreactivity with prognostic factors, discussing the
controversies of the method and questioning the possible
reasons for divergent results.
It is generally known that 50% of patients with T2
N0,1 M0 present non-compromised axilla, and, from these
cases, 29% undergo unfavourable evolution within five
years. However, this prognosis could be altered with the
adoption of adjuvant chemotherapy(16).
Considering that the anatomopathological parameters
are insufficient to support this indication, this study aimed
to analyse whether the association with a marker of
proliferative activity (PCNA) could provide a prognosis
of the tumor evolution and possibly suggest the type of
therapeutics needed following mastectomy. At the same
time, the study also investigated whether different
interpretation criteria could alter the results.
METHODS
Patients
A total of 59 patients with primary breast carcinoma
in clinical state II treated in the Mastology section of the
Gynecology Department of Escola Paulista de Medicina
between July 1985 and July 1994 were     selected to take
part in the study.
The cases included corresponded to state II (T2 N0
M0,T2 N1 M0) according to the T.N.M. system as
established by the International Union Against Cancer
(1988).
The patients were classified into two groups. The
first one (“Positive Axilla”; 27 patients) presented
neoplastic compromise of the lymph nodes, determined
by the anatomopathological examination, independent of
the number of compromised lymph nodes. The second
group (“Negative Axilla”; 32 patients), consisted of those
who did not present metastasis in the axillary lymph nodes.
The patients’ average ages in the “Positive” and
“Negative Axilla” groups were 53 and 56.6, respectively.
The average tumor diameter in the “Positive Axilla”
group was 3.2 cm and in the “Negative Axilla” group,
3.3 cm.
Anatomopathological Method
All material submitted to histological examination
was previously fixed in a 10% solution of saturated liquid
formaldehyde.
The slides were prepared in conformity with routine
techniques of the Pathology Department of Escola Paulista
de Medicina.
The slides corresponding to the primary tumor
were examined under optical microscope to determine
the following histological features: histological type,
histological grade, nuclear grade, mitotic index, necrosis
and vascular neoplastic embolization. Some of these
parameters, histological grade, nuclear grade and
mitosis were analysed quantitatively and semi-
quantitatively(17,18).
The analysis of the histological variables was
performed by two pathologists who had not been
previously informed of the groups to which the patients
belonged.
Immunohistochemical Method
The histological sections of the selected fragments
were performed in the Pathology Department of Escola
Paulista de Medicina and sent to the Immunopathology
section for immunohistochemical processing by the
Avidin-Biotin-peroxidase method (A.B.C.), as described
by Hsu et al(19).
Each reaction included a positive and a negative
control. The slides with positive controls were prepared
with tissues known to be positive for the studied antigens,
such as tonsil and intestinal mucosa. The negative-control
slides were prepared from the blocks of the studied cases
where, instead of using the primary antigen, a non-immune
mouse serum was used.
The primary antibody employed was the anti-PCNA
monoclonal antibody PC-10 from Dako (Denmark
Dakopatts A/S) code M879, lot 121, previously tested and
standardized for the dilution 1:80.
Immunohistochemical Interpretation
  The presence of PCNA in the neoplastic
compartment was determined.
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Table1
Percentages of the total of stained cells and the most
intensely stained ones evaluated among 1000 cells
in patients with state II breast carcinoma with
positive or negative axilla.
% Total of %  The most
stained cells intensely stained cells
Axilla + Axilla - Axilla + Axilla -
75.9 76.5 35.0 33.6
64.4 50.7 23.6 14.3
66.0 40.1 23.4 15.0
50.5 34.2 18.6   3.0
43.3 71.5 4.3 24.7
48.0 10.8 4.9   2.6
73.0 75.0 36.5 16.4
51.8 50.6 12.9 12.5
65.1 39.9 19.4 3.91
41.9 33.4   9.5 8.6
49.8 59.1   2.2 17.5
56.5 38.0   6.4 1.4
36.7 27.8   0.8   7.1
91.6 70.8 73.2   6.7
33.9 58.9   3.6   6.6
60.3 10.1   5.7   0.9
45.5 29.1   6.0   3.7
74.6 36.3 11.0   1.9
60.5 10.0 18.4   0.0
38.4 70.5   8.2 14.1
44.4 73.6   4.0 12.1
79.5 40.0 11.8 3.6
37.8 51.7   4.5 11.2
69.9 50.4 27.4   2.6
73.3 54.8 22.0   7.3
69.2 63.0 19.0   1.0
62.6 30.4 32.3   4.5
61.7 18.8
28.0 8.5
48.6 16.0
48.6 12.1
65.8 18.9
MEAN 57.9 47.2 16.5   9.5
Mann-Whitney Test  with approximation to the normal curve
(axilla+ X axilla-)
critical Z = 1.96
total of stained cells the most intensely
stained cells
calculated Z = 2.01* calculated Z = 1.88
axilla + > axilla -
The staining intensity was subjectively analysed and
the stained nuclei were quantified through the study of
1000 cells. This procedure was conducted with the help
of a 100x immersion objective with a final magnification
of 1000x .
The reaction was considered positive when nuclear
staining occurred in a diffuse way (dot matrix of variable
intensity) or granular (in clumps or homogeneously
distributed)(2,3).
Nuclei counts were conducted without the author’s
previous knowledge of the histological variables and the
groups to which each case belonged.
The number of stained nuclei was counted to a total
of 1000 cells, taking into account an area previously
selected as the most representative, to give the PCNA
index.
At the same time, the staining intensity was
determined semi-quantitatively as poor, moderate or
intense. The expression of the most intensely stained
nuclei was as a percentage referring only to the most
intensely stained ones of the 1000 cells.
From the initial 60 cases, only one presented a
negative reaction and was then consequently excluded from
the study. Thus, 59 patients were analysed.
Statistical Method
Non-parametric tests were utilized to assess the
results, considering the nature of the studied variables.
The following tests were applied: 1. Kruskal-Wallis rank
variance analysis, 2. Mann-Whitney test to compare the
“Positive” and “Negative Axilla” groups(20).
All the tests fixed the level for rejection of the null
hypothesis at 0.05 or 5% (P < 0.05), marking significant
values with an asterisk (*).
RESULTS
Correlation of patients’ ages and presence or absence
of necrosis and vascular embolization with positive or
negative axilla, evaluated by the Mann-Whitney or
Kruskal-Wallis tests, revealed that the PCNA index did
not show significant differences, neither for the total of
stained cells nor for the most intensely stained ones.
The Mann-Whitney test verified that the percentages
of the total of stained cells (PCNA index) in the “Positive
Axilla” group were significantly greater than the ones
observed in the “Negative Axilla”group (Table 1).
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DISCUSSION
The analysis of the 60 initial cases revealed that only
in one did the reaction not occur. The corresponding slide
of hematoxylin and eosin (H.E.) also exhibited poor tissue
preservation, probably due to inadequate fixation.
Homogeneously attenuated reactions observed in
another 7 cases may have been due to a prolonged fixation
process, as the direct visualization of the reaction on the
slides permitted the observation of good tissue conditions
and our consequent trust in the stained cells counts.
Fifty-two (86.7%) of the studied specimens presented
excellent results; and this figure reaches 98.4% when we
consider those 7 less reactive cases.
The concomitant presence of poor, moderate and
intensely-stained nuclei could be observed on analysis of
the remaining 59 patients. The aspect encountered was
diffuse or granular, or both. A heterogeneous distribution
pattern with predominant reaction areas could also be
observed.
The heterogeneous pattern found among the samples
and within the same sample is inherent to the
Figure 1 - Percentages of the total of stained cells (% PCNA)
evaluated among 1000 cells in patients with state II breast
carcinoma grouped according to nuclear grades NG1, NG2 and
NG3 with positive or negative axilla.
The Kruskal-Wallis test demonstrated that among the
nuclear grades NG1, NG2 and NG3 of the “Positive
Axilla” group, the tumors of NG3 presented a significantly
higher index of the total of stained cells (PCNA) when
compared to the ones encountered in NG1 (Fig.1).
Concerning the nuclear grades NG1, NG2 and NG3
of the “Negative Axilla” group, the results suggested that
the index of the total of stained cells (PCNA) in the NG3
were higher than the ones in NG2 and NG1.
Furthermore, correlations of the histological grades
HGI, HGII and HGIII with positive or negative axilla
(Fig.2) established by the Kruskal-Wallis test revealed that
the index of the total of stained cells (PCNA) in the
“Negative Axilla” group was significantly higher in the
patients presenting tumors of histological grade HGIII than
in patients with HGII and HGI tumors.
The same test applied among the patients of the
“Positive Axilla” group demonstrated that the percentages
of the total of stained cells (PCNA) in the histological grades
HGI, HGII and HGIII were not significantly different.
The Mann-Whitney test and Kruskal-Wallis analysis
did not show significant differences between the most
intensely stained cells and histological and nuclear grades
within either of the groups studied (“Positive Axilla” and
“Negative Axilla”).
Figure 2 - Percentages of the total of stained cells (% PCNA)
evaluated among 1000 cells in patients with breast carcinoma in
state II grouped according to histological grades I, II and III with
positive or negative axilla.
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immunoreactivity with PCNA. This happens because
tumor cells cycle asynchronously and cyclin expression
in each cell relies on the phase of the cycle in which it is
found(2).
Therefore, variability of reaction aspects or intensity
among the samples or even within the same field is
expected(5).
Observation of the above information provides
support for establishing criteria to be applied in the various
studies and from this, interpretation of the different results
is enabled.
Most authors considered the most representative
fields, ie those containing the highest numbers of positive
nuclei. Total cell counts ranged from 200 to 1000, always
evaluating the proportion of stained nuclei over total counts
and then expressing the PCNA percentage. According to
these authors, these figures would provide a measure of
the maximum proliferative tumor activity(5,9,10,13,14,15,21).
At the same time, several authors considered all the
stained nuclei as positive independently of staining
intensity, thus aiming to widely represent the S-phase of
the cellular cycle(2,4,5,9,10,13,15,21).
Other authors considered solely the most intensely
stained nuclei or only those presenting granular aspect,
eliminating weakly stained ones or those with diffuse
staining(8,12,22).
Having found heterogeneous fields, some researchers
made use of the mean of the are   mas presenting higher
and lower counts of stained nuclei(4,14,21).
In accordance with this procedure, the mean of the
areas from a total of 1000 evaluated cells(7) or a random
observation of 10 fields(6) was applied in computerized
image analysis.
With the aim of analysing the resultant data, the
authors made use of the PCNA percentages divided into
quartiles: 0-25%, 26-50%, 51-75%, 76-100%(5,9); or with
a slight modification: < 19%, 20-39%, 40-61%, > 62%(15).
Other investigators reported cyclin expression as high
or low in accordance with a cut-off value, which was
statistically determined as 18(12), 25(14), 30(8,11), or expressing
high significance when over 50(11).
Two different monoclonal antibodies were used: 19A2
diluted in a proportion of 1/800 and 1/1000(4,6), and PC-10
in dilutions ranging from 1/15 to 1/800(5,7,8,9,10,12,13,15,21).
In the present study, we selected the most
representative areas, successively counting nuclei in
contiguous fields. Areas demonstrating necrosis or intense
demoplasic reaction, where cell preservation or quantity
were affected independently of staining, were discarded
in an attempt to make the selected fields as homogeneous
as possible.
Cell counts were performed and the cells were
separated into 2 groups. The first group considered all the
stained nuclei, independently of the aspect or intensity,
whereas the second group comprised only the most
intensely stained ones.
In order to assess the importance of the PCNA
percentages encountered, these figures were compared
with the available classic anatomopathological or clinical
parameters.
In our series, 49 (83%) were invasive ductal carcinomas
(47 pure and 2 mixed). Another 3 were “pure” infiltrative
lobular carcinomas. The mean cyclin value for these cases
(62.7) was higher than the one observed for the invasive ductal
carcinomas (52.1), in agreement with Tahan’s findings(12). For
the remaining subtypes, the unitary sampling of each one did
not allow a comparative analysis (Fig. 2).
In our material, the age, the presence or absence of
necrosis, or vascular embolization did not present
significant differences in the PCNA percentages among
the “Positive” or “Negative” groups for the 2 analysed
series of cells, ie total of stained cells or only the most
intensely stained ones.
Evaluating the significant results relating to the first
group (the percentage of the total cells stained by PCNA),
PCNA values in the “Positive Axilla” group were
significantly higher than the ones presented by the
“Negative Axilla” (Table 1).
Haerslav and Jacobsen(23), analysing 509 patients with
cancers of different sizes, also encountered a higher
PCNA-mean in tumors presenting metastases in axillary
lymph nodes.
A comparison of the indices of total stained cells by
PCNA and histological and nuclear grading shows that in
the “Positive Axilla” group the mean PCNA values
increased in association with the increase of nuclear
grading. For the “Negative Axilla” group, a similar
tendency was observed. Although the sample size did not
allow the detection of a significant difference, the results
suggest that NG3 is higher than NG1 and NG2 (Fig.1).
 With regard to histological grading, an upward
tendency of PCNA percentages in conformity with the
grading was verified for the “Negative Axilla” group and
significant differences were detected between HGIII and
HGI, yet for the “Positive Axilla” group, mean values of
this antigen in HGI, HGII and HGIII were more uniform
and did not reveal significant disparities (Fig. 2).
The results obtained with histological and nuclear
grades were not in agreement with other authors’
findings(13,14,15,21).
 Thomas(14) and Gasparini(15) made use of PC-10
diluted to 1/200 and 1/300, respectively. Leonardi(21) and
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Sullivan(13) considered the mean value of fields with high
and low PCNA percentages to express the reaction value
in each case. In addition to this, Leonardi(21) used the PC-
10 antibody diluted to 1/400 when fixed in formaldehyde
and 1/800 when fixed in metacarnoy. Furthermore, the total
count comprised 500 cells.
 These various dilutions and criteria employed in the
studies may interfere with the homogeneity of the results.
 On the other hand, similarities were encountered
between our study and several other studies. Many of these
studies confirmed the significant correlation of PCNA
percentages with nuclear and histological grades, even
showing evidence of this scaled proportion(6,7,8,9,10,12).
 Moreover, a significant correlation was established
between nuclear grade 3 and high indices of PCNA, Ki67
and aneuploidal tumors through computerized image
analysis, indicating a worse prognosis. An inverse relation
in these indices and a good prognosis was connected with
nuclear grade 1(6). At the same time, a worsening of nuclear
grades was significantly associated with tumor recurrence(9).
 The results of PCNA-positivity found exclusively
through counts of the most intensely stained cells were
not significant within the “Positive Axilla” or “Negative
Axilla” groups, concerning the type of involvement of
axillary lymph nodes.
Similarly, no significant differences were found
between the groups “Positive Axilla” and “Negative
Axilla” regarding nuclear and histological grading.
Thus, these data provide evidence that it is more
appropriate to consider all the stained cells as a
representation of PCNA indices for demonstrating the
worsening of histological and nuclear grades, and more
clearly demonstrating the differences in these indices in
the “Positive Axilla” or “Negative Axilla”groups, thus
better reflecting tumor aggressiveness.
From the prognostic viewpoint, higher nuclear and/
or histological grades, associated with increased PCNA
values had already revealed the property of identifying
groups of patients with a high risk of recurrence,
particularly when a negative axilla was found(6,8,9,22,23).
 In our material, from the 59 cases studied, 27 had a
negative axilla. From these, PCNA values above 50 and
NG3 or HGIII determined 7(25.9%) and 8(29.6%) cases,
respectively, considering the total of stained cells.
Based on the data analysed up until the present
moment, we can conclude that the above-mentioned group
of patients is characterized as a high-risk group for tumor
recurrence and there is a necessity for systemic
chemotherapy treatment.
Taking into account solely PCNA values over 50,
we have the cases discussed above which were associated
with HGIII and/or NG3, three associated with NG1 and
six with NG2.
 From those associated with NG1, two corresponded
to the invasive lobular histological type, which are
considered as having the worst prognosis(12).
 From the other six classified as NG2 and HGII, five
were infiltrative ductal carcinomas, and from these, three
presented necrosis and vascular embolization, which are
parameters regarded as unfavourable when analysed
altogether(24). It is worth adding that tumors of heterogeneous
composition (distinct cellular clones) frequently run a course
similar to more undifferentiated ones(24). Thus, they are also
connected with a bad prognosis. Narita(11) had already
reported that levels above 50 identified patients with a bad
prognosis, equal to what was defined in our study.
 It was also concluded that false judgements and
disagreements concerning the evaluation of proliferative
tumor activity may come from the sample selection, in the
field chosen to count the cells or in the different aspects
and intensities regarded as positive for the PCNA on a
given smear.
Perhaps this has given rise to most of the disagreements
among different observers. The most troublesome task after
witnessing a selection criterion is transmitting the
reproducibility threshold of this element to distant observers.
For this method, it would be the threshold of aspects or
staining intensity of the counted cells.
The criterion of slide evaluation, which was best
correlated with the anatomopathological parameters and
enabled better uniformity of analysis among the results
obtained by the different authors, and also by us, was to
consider the total of stained cells as representative of
PCNA values.
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RESUMO
Estudou-se o valor prognóstico do antígeno nuclear de proliferação celular (PCNA/Ciclina) em 59 pacientes do Estadio II (T2,
N0,1, M0). As pacientes foram separadas de acordo com comprometimento dos linfonodos axilares, com dois grupos, ditos
“Axila Positiva” e “Axilia Negativa”. Determinou-se a presença do PCNA através do método Avidin-Biotinaperoxidase utilizando
o anticorpo monoclonal PC-10. Fez-se a contagem das células no campos mais representativos e contíguos, sempre observando
o número de células coradas sobre o total de células contadas, em dois conjuntos, ou seja, total de células coradas e o das
mais intensamente coradas. Cotejou-se esses valores com os parâmetros, idade, tamanho do tumor, graus nuclear e histológico
e o estado de envolvimento dos linfonodos axilares. Observou-se que o falso juízo e as divergências na avaliação da atividade
proliferativa dos tumores podem advir da seleção das amostras, do campo escolhido para contar as células ou dos diferentes
aspectos e intensidade consideradas como positivo para o PCNA. Notou-se haver significante associação com valores crescentes
da ciclina e a piorea na classificação dos graus nuclear e histológico, em particular, nas pacientes que tinham axila negativa.
Sob o ponto de vista prognóstico, a graduação mais elevada do grau nuclear (GN3) e do histológico (GHIII) associaram-se a
altos índices de PCNA (>50) e distingüem um grupo de pacientes de alto risco; isto é particularmente importante quando as
pacientes têm axila negativa e há necessidade de tratamento sistêmico quimioterápico. Verificou-se ser, essa técnica, simples,
reproduzível e facilmente adaptável à rotina laboratorial.
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